This TIP, Substance Abuse Treatment for Persons With Co-Occurring Disorders, revises TIP 9, Assessment and Treatment of Patients With Coexisting Mental Illness and Alcohol and Other Drug Abuse. The revised TIP provides information about new developments in the rapidly growing field of co-occurring substance use and mental disorders and captures the state-of-the-art in the treatment of people with co-occurring disorders. The TIP focuses on what the substance abuse treatment clinician needs to know and provides that information in an accessible manner. The TIP synthesizes knowledge and grounds it in the practical realities of clinical cases and real situations so the reader will come away with increased knowledge, encouragement, and resourcefulness in working with clients with co-occurring disorders.

Contents

• Acknowledgments
• What Is a TIP?
• Consensus Panel
• KAP Expert Panel and Federal Government Participants
• Foreword
• Executive Summary
• 1 Introduction
  • Overview
  • The Evolving Field of Co-Occurring Disorders
  • Important Developments That Led to This TIP
  • Organization of This TIP
• 2 Definitions, Terms, and Classification Systems for Co-Occurring Disorders
  • Overview
  • Terms Related to Substance Use Disorders
  • Terms Related to Mental Disorders
  • Terms Related to Clients
  • Terms Related to Treatment
  • Terms Related to Programs
  • Terms Related to Systems
• 3 Keys to Successful Programming
  • Overview
  • Guiding Principles
  • Delivery of Services
  • Improving Substance Abuse Treatment Systems and Programs
  • Workforce Development and Staff Support
• 4 Assessment
  • Overview
  • Screening and Basic Assessment for COD
  • The Assessment Process
• 5 Strategies for Working With Clients With Co-Occurring Disorders
  • Overview
  • Guidelines for a Successful Therapeutic Relationship With a Client Who Has COD
  • Techniques for Working With Clients With COD
• 6 Traditional Settings and Models
  • Overview
  • Essential Programming for Clients With COD
  • Outpatient Substance Abuse Treatment Programs for Clients With COD
  • Residential Substance Abuse Treatment Programs for Clients With COD
• 7 Special Settings and Specific Populations
  • Overview
  • Acute Care and Other Medical Settings
  • Dual Recovery Mutual Self-Help Programs
  • Specific Populations
• 8 A Brief Overview of Specific Mental Disorders and Cross-Cutting Issues
  • Overview
  • Cross-Cutting Issues
  • Personality Disorders
  • Mood Disorders and Anxiety Disorders
  • Schizophrenia and Other Psychotic Disorders
  • Attention Deficit/Hyperactivity Disorder (AD/HD)
  • Posttraumatic Stress Disorder (PTSD)
  • Eating Disorders
  • Pathological Gambling
  • Conclusion
• 9 Substance-Induced Disorders
  • Overview
  • Description
  • Diagnostic Considerations
  • Case Studies: Identifying Disorders
• Appendix A: Bibliography
• Appendix B: Acronyms
• Appendix C: Glossary of Terms
• Appendix D: Specific Mental Disorders: Additional Guidance for the Counselor
• Appendix E: Emerging Models
• Appendix F: Common Medications for Disorders
• Appendix G: Screening and Assessment Instruments
• Appendix H: Screening Instruments
• Appendix I: Selected Sources of Training
• Appendix J: Dual Recovery Mutual Self-Help Programs and Other Resources for Consumers and Providers
• Appendix K: Confidentiality
• Appendix L: Resource Panel
• Appendix M: Cultural Competency and Diversity Network Participants
• Appendix N: Field Reviewers

Suggested citation:

Center for Substance Abuse Treatment. Substance Abuse Treatment for Persons With Co-Occurring Disorders. Treatment Improvement Protocol (TIP) Series 42. DHHS Publication No. (SMA) 05-3922. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2005.

The opinions expressed herein are the views of the Consensus Panel members and do not necessarily reflect the official position of CSAT, SAMHSA, or DHHS. No official support of or endorsement by CSAT, SAMHSA, or DHHS for these opinions or for particular instruments, software, or resources described in this document are intended or should be inferred. The guidelines in this document should not be considered substitutes for individualized client care and treatment decisions.